3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Thoracic Diseases
1
Lung Neoplasms
1
Interventions
Dexamethasone
13
Bevacizumab
9
Saline Solution
8
Bupivacaine
8
Tobacco Use Cessation Devices
7
Specimen Handling
7
Nivolumab
7
Magnetic Resonance Spectroscopy
7
Lenalidomide
7
Fluorouracil
7
pembrolizumab
6
Rituximab
6
Prednisone
6
Letrozole
6
Cisplatin
6
Carboplatin
6
Sodium Chloride
5
Ropivacaine
5
Propofol
5
Human Papillomavirus Recombinant Vaccine nonavalent
5
trametinib
4
lenvatinib
4
dabrafenib
4
cabozantinib
4
anlotinib
4
Trastuzumab
4
Tamoxifen
4
Standard of Care
4
Paclitaxel
4
Immune Checkpoint Inhibitors
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
(2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol
×
1 year
×
Clear all
NCT07028593
2026-01-28
CP-MINS
Tongji Hospital
Phase 4
Recruiting
1,058 enrolled